Zoetis (ZTS): analysis and statistics
Return, volatility, Sharpe ratio and risk for Zoetis, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $77.80 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | -19.71% |
| Total return over period | -48.05% |
| Annualized volatility | 30.48% |
| Period volatility | 52.66% |
| Period T-bill | 12.40% |
| Sharpe ratio | -1.15 |
| Sortino ratio | -1.43 |
| Max drawdown | -64.16% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.87% |
| Correlation with the S&P 500 | 0.28 |
| Period range | $69.10 – $192.80 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Zoetis (ZTS) has posted an annualized return of -19.71% with annual volatility of 30.48%, a negative Sharpe ratio: over this period it did not beat the risk-free Treasury rate. Its worst stretch (max drawdown from a peak) was -64.16%. Its correlation with the S&P 500 is 0.28, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how ZTS would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with ZTS →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Zoetis (ZTS) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio